The pharmaceutical industry is in a period of sustained expansion, experiencing mid-single-digit compound annual growth rates for the past several years, a trend that is projected to continue through ...

Merck's affordable Ebola vaccine initiatives, Abbott's profit challenges, U.S. vaccination policy changes under Health ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

Quick Read VanEck Pharmaceutical ETF (PPH) surged 26% over the past year driven by weight-loss drug demand. Eli Lilly and ...

Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to ...

Now, the Chicago-based pharma is heading southwest as it charts the next leg of its stateside investment tour.

TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products ...

A $200 million transaction between owner Serán Bioscience and Bain Capital Life Sciences in 2024 helped support the buildout ...

THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...

AbbVie (ABBV) has agreed to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property ...

In May 2025, the Trump administration issued an executive order titled “Regulatory Relief to Promote Domestic Production of Critical Medicines” directing the Food and Drug Administration (FDA) and the ...